In The News
Cybersecurity class actions to increase with latest reforms
WestConnex class action funder loses fight with lead plaintiffs
New judge has a way with words, but does away with Twitter
Real estate ‘mogul’ Sasha Hopkins to cop $1.25M penalty in ASIC case
Bruce Lehrmann expands appeal in defamation case
Judge questions Jarryd Hayne supporter’s defamation appeal
Herbert Smith Freehills snags Allens tax partner
Privacy reform kicks off with new tort for ‘serious’ invasions
Threat of class actions keeping in-house counsel up at night: report
Judge who steered Victorian Supreme Court through pandemic to step down
Please login to bookmarkClose

Pharmaceutical giants Merck Sharpe & Dohme and Pfizer have resolved a long-running intellectual property dispute over a 2015 patent owned by Pfizer for a pneumococcal vaccine.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?
Lost your password?

Contact us to enquire about group subscriptions.
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au